Search results for: 'many'

This market engineering research service has been developed to address the advanced wound management in Taiwan. This research service presents the key findings of market. It provides insights and forecast of market size, overview, and strategic recommendations. This research service also discusses market trends, market drivers, and market restraint...

With a population of 620 million, ASEAN represents approximately 8.6% of the global population. With a combined GDP of US$2.4 trillion in 2013, growing at an average annual rate of 5.6%, the region’s economic growth outpaces many other regional and global economies. Demand for healthcare services is expected to surge due to factors such as populati...

21 Aug 2018  |  Asia Pacific  |  Market Research

Future of Electronic Medical Record and Electronic Health Record in Asia-Pacific, Forecast to 2023

Product Innovation is the Answer for Sustainability in a Dynamic Market

Infographics

×

The governments and providers in Asia-Pacific (APAC) are focused on reducing medical expenses while improving population health and well-being. A shortage of medical professionals is seen across multiple specialties in various APAC countries; moreover, clinicians are concentrated in urban areas leading to disproportionate clinician–to-patient ratio...

Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...

The South Korean endoscopy devices market is growing under relatively lower reimbursement rates and budget constraints that are forcing hospitals to provide greater importance to pricing of equipment and changing utilization patterns. In many South Korean hospitals, consolidated purchasing of endoscopy and laparoscopy equipment slows down procureme...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...